No current affiliations available for this person. The person is no longer active at the university.

Hypothyroidism correlates with a better prognosis in metastatic renal cancer patients treated with sorafenib or sunitinib. Riesenbeck LM, Bierer S, Hoffmeister I, Köpke T, Papavassilis P, Hertle L, Thielen B, Herrmann E (2011) In: World Journal of Urology, 29(6) Type of Publication: Research article (journal)
Negative predictive value of systematic ultrasound-guided prostate biopsy: which tumours do we miss? Köpke T, Oberpenning F, Bettendorf O, Eltze E, Herrmann E, Hertle L, Weining C, Wulfing C, Semjonow A (2010) In: Anticancer Research, 30(5) Type of Publication: Research article (journal)
Pre-analytical in-vitro stability of [-2]proPSA in blood and serum. Semjonow A, Köpke T, Eltze E, Pepping-Schefers B, Bürgel H, Darte C (2010) In: Clinical Biochemistry, 43(10-11) Type of Publication: Research article (journal)
Pre-treatment global quality of health predicts progression free survival in metastatic kidney cancer patients treated with sorafenib or sunitinib. Herrmann E, Gerss J, Bierer S, Köpke T, Bolenz C, Hertle L, Wülfing C (2009) In: Journal of Cancer Research and Clinical Oncology, 135(1) Type of Publication: Research article (journal)
Clinical staging error in prostate cancer: localization and relevance of undetected tumour areas. Bolenz C, Gierth M, Grobholz R, Köpke T, Semjonow A, Weiss C, Alken P, Michel MS, Trojan L (2009) In: BJU International, 103(9) Type of Publication: Research article (journal)

Optimierung der Biopsiestrategie in der Diagnostik des Prostatakarzinoms
Candidate: Köpke, Thomas | Supervisors: Semjonow, Axel
Period of time: until 10/05/2007
Doctoral examination procedure finished at: Doctoral examination procedure at University of Münster